New research increases understanding of drug effects in treatment of Alzheimer's Disease
Monday, September 19, 2011 - 09:01
in Health & Medicine
Just like one size doesnt fit all, it appears that some pharmaceuticals designed to improve mental ability may do the opposite when given to people with normal mental function. Scientists from Trinity College Dublin, in a collaboration between the Trinity College Institute of Neuroscience, the pharmaceutical company GlaxoSmithKline and St. Jamess Hospital Dublin, have used a novel combination of technologies to better understand the mechanics of a commonly prescribed medication for Alzheimers Disease. The collaboration is supported by the Irish Development Agency (IDA).
